5 employees
Argonaut Therapeutics is a precision therapeutics company that was established to develop epigenetically-acting drugs which target abnormal.
2016
$2.6M
from 2 investors over 2 rounds
Argonaut Therapeutics raised $2.6M on October 29, 2018
Investors: JW Pharmaceutical Corporation
Argonaut Therapeutics raised undisclosed on October 1, 2016
Investors: Oxford Sciences Innovation